Hemochromatosis secondary prevention

Hemochromatosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hemochromatosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Hemochromatosis secondary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hemochromatosis secondary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hemochromatosis secondary prevention
CDC on Hemochromatosis secondary prevention
Hemochromatosis secondary prevention in the news
Blogs on Hemochromatosis secondary prevention
Directions to Hospitals Treating Hemochromatosis
Risk calculators and risk factors for Hemochromatosis secondary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sunny Kumar MD [2]

Overview

We can treat hemochromatosis with many options depending on level and cause of increased iron load in body.

Secondary Prevention

Hemochromatosis can be prevented secondarily by:

• Dietary modifications
• Phelbtomy
• Avoiding alcohal
• Avoiding iron supplements
• Iron chelation therapy
•  Genetic testing